Neus Baena | Genetics and Genomics | Best Researcher Award

Prof. Dr. Neus Baena | Genetics and Genomics | Best Researcher Award

Consorci Corporacio Parc Tauli | Spain

Prof. Dr Neus Baena with a strong academic foundation in genetics, anthropology, and biomedical sciences, this scholar has made remarkable contributions to the fields of human genetics, embryology, and molecular diagnostics. With a portfolio of 44 documents, 1048 citations, and an h-index of 17, their research emphasizes the genetic and neurobiological mechanisms underlying human development and disease. Educated and trained at leading Catalonian institutions such as the Universitat Autònoma de Barcelona, Universitat de Barcelona, and the Institut Universitari Dexeus, they have completed advanced coursework in biochemistry of reproduction, prenatal diagnosis, neurobiology, genetic engineering, and clinical cytogenetics. Their professional experience spans genetics, anthropology, and clinical biology, reflecting an interdisciplinary approach bridging molecular science and human evolution. Research interests include cytogenetics, genetic pathology, embryological development, and neurogenetics, with a focus on disease mechanisms and evolutionary implications. The researcher has actively participated in specialized programs led by prominent professors like Dr. J.M. Dexeus, Dr. L. Vilageliu, and Dr. R. Miró. Recognized for academic excellence and continuous professional development, they have contributed to expanding the understanding of human biology through rigorous study and laboratory innovation, embodying a commitment to advancing biomedical and anthropological sciences.

Profiles : Scopus | Orcid

Featured Publications

Blanco, J., Gabau, E., Gómez, D., Baena, N., Guitart, M., Egozcue, J., & Vidal, F. (1998). Chromosome 21 disomy in the spermatozoa of the fathers of children with trisomy 21, in a population with a high prevalence of Down syndrome: Increased incidence in cases of paternal origin. American Journal of Human Genetics, 63(4), 1067–1072.

Gómez, D., Solsona, E., Guitart, M., Baena, N., Gabau, E., Egozcue, J., & Caballín, M. R. (2000). Origin of trisomy 21 in Down syndrome cases from a Spanish population registry. Annales de Génétique, 43(1), 23–28.

De Vigan, C., Baena, N., Cariati, E., Clementi, M., & Stoll, C.; EUROSCAN Working Group. (2001). Contribution of ultrasonographic examination to the prenatal detection of chromosomal abnormalities in 19 centres across Europe. Annales de Génétique, 44(4), 209–217.

Baena, N., Guitart, M., Ferreres, J. C., Gabau, E., Corona, M., Mellado, F., Egozcue, J., & Caballín, M. R. (2001). Fetal and placenta chromosome constitution in 237 pregnancy losses. Annales de Génétique, 44(2), 83–88.

Baena, N., De Vigan, C., Cariati, E., Clementi, M., Stoll, C., Caballín, M. R., & Guitart, M.; EUROSCAN Working Group. (2003). Prenatal detection of rare chromosomal autosomal abnormalities in Europe. American Journal of Medical Genetics Part A, 118A(4), 319–327.

Muhammad Riaz | Biology and Life Sciences | Best Researcher Award

Dr. Muhammad Riaz | Biology and Life Sciences | Best Researcher Award

Rehman Medical Institute | Pakistan

Dr. Muhammad Riaz is a distinguished microbiologist with over eleven years of progressive experience in clinical laboratory diagnostics and supervision. He earned his PhD in Microbiology from Sarhad University of Science & Information Technology, an MPhil in Medical Microbiology from the University of Peshawar, an MSc in Microbiology from the University of Karachi, and a BSc in Medical Laboratory Technology. His career has spanned roles such as Senior Laboratory Technologist, Laboratory Supervisor, and Lecturer, in which he has overseen bacterial culture, isolation, biochemical identification, antimicrobial susceptibility testing (following CLSI & EUCAST standards), molecular diagnostics (PCR), media preparation, staining, biochemical testing, and quality assurance under regulated biosafety conditions. His research has focused on antimicrobial resistance—studies include works on Salmonella Typhi, Klebsiella pneumoniae, Multidrug-Resistant Mycobacterium tuberculosis, Extensively Drug-Resistant Typhi, and Candida auris. He has participated in conferences, training workshops (e.g. ISO 15189, Infection Prevention & Control), and published multiple peer-reviewed articles; his work has accrued dozens of documents and citations in national and international journals. Dr. Riaz is also engaged in mentoring, outbreak preparedness, and diagnostic stewardship. His research interests include resistome profiling, molecular epidemiology, antimicrobial resistance surveillance, diagnostic innovation, and public health microbiology. He has received recognition for his commitment to laboratory excellence and continues to contribute to improvements in diagnostics, patient care, and infection control.

Profile : Orcid

Featured Publications

Riaz, M., Ahmad, S., Sattar, F., Li, G., Din, Z. U., Ahmad, S., Azra, A., Waheed, A., Ul Haq, I., & Phelan, J. E. (2025). Whole-genome sequencing analysis of drug-resistant Salmonella Typhi in children. Pathogens, 14(10), 967.

Din, Z. U., Ullah, F., Khan, A. S., Ahmad, S., Azra, A., Waheed, A., Muhammad, N., Ali, F., Khattak, F. A., Rani, G. F., & Riaz, M. (2025). Genomic insights into pyrazinamide and fluoroquinolone resistance in multidrug-resistant tuberculosis in Khyber Pakhtunkhwa, Pakistan.International Journal of Medical Microbiology.

Khan, M., Khattak, M. T., Gul, A., Riaz, M., & Zahra, F. T. (2024). A comparable risk of extensively drug-resistant typhoid fever in the pediatric cohort during the COVID-19 pandemic. International Journal of Health Sciences.

Riaz, M., Khan, I., Khan, S., Sattar, F., & Khan, M. I. (2023). Study on multidrug, extensive drug and pan drug resistance in septicemic infants. IPS Journal of Applied Microbiology and Biotechnology, 2(1), 12.

Riaz, M. (2017). Outcome of 12-weeks triple therapy (TT), including sofosbuvir (SOF), ribavirin and pegylated interferon-alfa in all non-cirrhotic patients with chronic hepatitis-C genotype-3 infection. Medical Forum, 28(7).

Marwa Hassan | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Marwa Hassan | Molecular Biology | Best Researcher Award

Theodor Bilharz Research Institute | Egypt

Marwa Hassan is an immunologist with substantive contributions in stem cell biology, molecular immunology, and translational research. She also holds a Postgraduate Diploma in Healthcare & Hospital Management (American University in Cairo, 2020). Over her career she has held roles from resident researcher to acting head of department at the Immunology Division of TBRI, and has organized and led numerous specialized training courses (e.g. stem cell culture, molecular immunology, ELISA). Her research interests include non-coding RNAs, stem cell differentiation, immune regulation in liver disease, and biomarker development. She has published in peer-reviewed journals (e.g. on circulating liver cancer stem cells) and contributed to capacity building via workshops and academic leadership. Her awards and recognitions reflect her dual strengths in research and academic service. In sum, Dr. Hassan combines rigorous scientific inquiry with institutional leadership, advancing immunology and regenerative medicine in Egypt and beyond.

Profile : Orcid

Featured Publications

Ahmed, M. H. M., & Abdel Hamid, H. M. (2022). Circulating liver cancer stem cells: Clinical implications and future perspectives. World Journal of Gastroenterology, 28(1), 39–52

Ahmed, M. H. M., El Refai, S., & El-Shenawy, R. (2021). MicroRNA-based biomarkers in hepatitis C virus-induced hepatocellular carcinoma. Egyptian Journal of Immunology, 28(2), 75–90.

Ahmed, M. H. M., Hussein, M., & El Sayed, A. (2020). Impact of mesenchymal stem cell passaging on proliferation and differentiation potential. Theodor Bilharz Medical Journal, 18(4), 201–210.

Ahmed, M. H. M., Ibrahim, N., & Khalifa, M. (2019). Role of regulatory T-cells in autoimmune liver diseases: An immunopathological study. Journal of Clinical and Experimental Hepatology, 9(3), 355–362.

Ahmed, M. H. M., & El Demerdash, R. (2017). Gene expression profiling of umbilical cord blood-derived mesenchymal stem cells under oxidative stress. Stem Cell Research & Therapy, 8(1), 112.

Ehsan Khedre | Biology and Life Sciences | Best Researcher Award

Dr. Ehsan Khedre | Biology and Life Sciences | Best Researcher Award

Egyptian Drug Authority Pyramids Branch | Egypt

Dr. Ehsan Khedre is a pharmaceutical biochemistry researcher whose work spans natural product pharmacology, nanotechnology, oxidative stress, and metabolic disease. After earning her B.Pharm (Ain-Shams University, Egypt, 2004), she completed an M.Sc. in Biochemistry (Zagazig University, 2011) and a Ph.D. (Al-Azhar University, 2018) on estrogenic effects of quercetin and its nanoparticles. She has held roles at Egypt’s National Organization for Drug Control & Research (NODCAR / EDA), advancing from drug control specialist to quality manager and researcher in biochemical laboratories. Her publication record (to date > 9 peer-reviewed articles) includes studies on hepatic fibrosis, nanocarrier enhancement of phytochemicals, metabolic syndrome models, and nanoparticle biodistribution. Her citation metrics h-index of 5, total documents 7, total citations 170 reflect her growing impact in pharmacology and toxicology. Her research interests include antioxidant and anti-inflammatory natural compounds, nanoparticle delivery systems, biochemical mechanisms of organ injury, and translational approaches to metabolic and hepatic diseases. She has also contributed by serving as reviewer for journals, receiving training in quality systems (ISO 9001 / ISO 17025), scientific writing, bioinformatics, and innovation, and participating in workshops on research skills. In sum, Dr. Khedre combines deep domain expertise, laboratory leadership, and interdisciplinary scholarship to advance discovery and application of therapeutics.

Profiles : Orcid | Scopus

Featured Publications

Fayed, E. A., El-Sebaey, S. A., Ebrahim, M. A., Abu-Elfotuh, K., El-Sayed Mansour, R., Mohamed, E. K., Hamdan, A. M. E., Al-subaie, F. T., Albalawi, G. S., Albalawi, T. M., et al. (2025). Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-vivo and in-vitro assays, ADMET and molecular docking simulation. European Journal of Medicinal Chemistry, 117201.

Abu-Elfotuh, K., Kamel, G. A. M., Najm, M. A. A., Hamdan, A. M. E., Koullah, M. T., Fahmy, R. K. E., Aboelsoud, H. A., Alghusn, M. A., Albalawi, B. R., Atwa, A. M., et al. (2025). Modulating multiple molecular trajectories by nutraceuticals and/or physical activity in attention-deficit/hyperactivity disorder (ADHD)-like behaviors in rat pups. Journal of NeuroImmune Pharmacology.

Oudah, K. H., Najm, M. A. A., Ramsis, T. M., Ebrahim, M. A., Gohar, N. A., Abu-Elfotuh, K., Mohamed, E. K., Hamdan, A. M. E., Hamdan, A. M., Almotairi, R., et al. (2025). Unlocking therapeutic potential of novel thieno-oxazepine hybrids as multi-target inhibitors of AChE/BChE and evaluation against Alzheimer’s disease: In vivo, in vitro, histopathological, and docking studies. Pharmaceuticals, 18(8), 1214.

Nazeam, J. A., Black, I., Mulamoottil, V. A., Selim, N. M., El Shiekh, R. A., Abu-Elfotuh, K., Hamdan, A. M. E., Gowifel, A. M. H., Hafez, S. M., Mohamed, E. K., et al. (2025). Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes. International Immunopharmacology, 114110.

Mohamed, E. K., Fathy, M. M., Sadek, N. A., & Eldosoki, D. E. (2024). The effects of rutin coat on the biodistribution and toxicities of iron oxide nanoparticles in rats. Journal of Nanoparticle Research, 26(3), 49.

Manouchehr Fadaee | Medicine and Health Sciences | Best Researcher Award

Dr. Manouchehr Fadaee | Medicine and Health Sciences | Best Researcher Award

Tabriz University of Medical Sciences | Iran

Dr. Manouchehr Fadaee is an accomplished researcher recognized for his contributions to microbiology, immunology, cancer biology, and host–pathogen interactions.  demonstrating consistent productivity and influence in the field. His academic journey is rooted in biomedical sciences, where he advanced his expertise in immunotherapy, cancer progression, gut microbiome, infectious diseases, and exosome-mediated communication. Dr. Fadaee has experience collaborating with international journals, contributing impactful reviews and original research articles in leading platforms such as Journal of Drug Targeting, Cancer Cell International, Cell Communication and Signaling, Breast Cancer Research, and American Journal of Reproductive Immunology. His research interests span exosome-based therapies, postbiotics, gut microbiota, autoimmunity, cancer immunotherapy, and novel antimicrobial strategies. Beyond research, he has actively served as a peer reviewer for journals including Journal of Drug Targeting and Cell Biology International, enhancing the quality of scientific discourse. With several impactful works on immunotherapy and microbial interventions, Dr. Fadaee continues to advance innovative approaches to combat cancer and infectious diseases, making him a promising leader in biomedical research.

Profile : Orcid

Featured Publications

“The Cytotoxic and Immune‐Regulatory Roles of CD8+T Cell‐Derived Exosomes in Cancer: A Systematic Review”

“Gut microbiome and colorectal cancer: From pathogenesis to treatment”

“Potential of Vaginal Microbiota Transplantation (VMT) in Endometritis Management”

“Cyclophosphamide‐Induced Infertility and the Impact of Antioxidants”

“Exosome therapeutics for non-small cell lung cancer tumorigenesis”